Association and predictive value analysis for metabolic syndrome on systolic and diastolic heart failure in high-risk patients

Table 4 Final model using backward stepwise multinomial logistic regression analysis to include MetS for SHF and DHF

Model	Variables	β	SE	P value	OR	95% CI
DHF v.s Control	Age	0.672	0.156	<0.001	1.96	1.44-2.65
	LVMI	0.015	0.006	0.008	1.02	1.00-1.02
	HR	0.914	0.381	0.017	2.49	1.18-5.26
	Anti-lipids drug	-0.706	0.412	0.087	0.49	0.22-1.10
	MetS	0.497	0.175	0.004	1.64	1.16-2.31
	Intercept	-5.317	0.888	<0.001
SHF v.s Control	Age	0.690	0.195	<0.001	1.99	1.36-2.92
	LVMI	0.040	0.007	<0.001	1.04	1.02-1.05
	HR	1.807	0.414	<0.001	6.09	2.70-13.72
	Anti-lipids drug	0.328	0.450	0.466	1.39	0.57-3.35
	MetS	0.286	0.105	0.043	1.33	1.08-1.64
	Intercept	-9.998	1.182	<0.001

Note: Age, gender, smoking, HR, Ccr, UA, LVMI, anti-Lips, anti-hypertension and lowering lipids drugs and CAD are stated to enter multinomial logistic regression analysis. MetS- metabolic syndrome, LVMI- left ventricular mass index, HR- heart rate.

ISSN: 1471-2261